Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed: 18,156
Companies: 1,062
Drugs tracked: 3,187

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources

Quick answer

Amikacin Inhalation Solution (BAY41-6551)

Bempegaldesleukin

Bempegaldesleukin

Inhaled Human Insulin

NKTR-102

NKTR-102

NKTR-181 BID tablets

NKTR-214

NKTR-255 at 1.5 µg/kg

Nivolumab

bempegaldesleukin

Amikacin (BAY41-6551)

Amikacin inhalation solution (BAY41-6551)

Avelumab

Bempegaldesleukin

Dose Escalation Doublet: Combination of NKTR-214 + nivolumab

Dronabinol MDI

Etirinotecan pegol

LY3471851

LY3471851

NKTR-102

NKTR-102

NKTR-102 100 mg/m2

NKTR-102 145 mg/m2

Frequently asked questions